Chapter 414 — Medical Assistance
ORS 414.369 Prospective drug use review program
The prospective drug use review program must use guidelines established by the Oregon Health Authority that are based on the recommendations of the Pharmacy and Therapeutics Committee. The program must ensure that prior to the prescription being filled or delivered a review will be conducted by the pharmacist at the point of sale to screen for potential drug therapy problems resulting from the following:
Therapeutic duplication.
Drug-drug interactions, including serious interactions with nonprescription or over-the-counter drugs.
Incorrect dosage and duration of treatment.
Drug-allergy interactions.
Clinical abuse and misuse.
Drug-disease contraindications.
Note: See note under 414.351.
Official sources · 1Tap to view provenance and version history
Provenance
2025 Oregon Revised Statutes — official online source
Official online edition
- Source
- oregonlegislature.gov
- SHA-256
51ac3b8d…5b47e954- Review
- auto verified
Version history
Prior statutory text is not available in the ingested published editions. Consult an earlier official ORS edition or the cited Oregon Laws chapter.
2025 Oregon Revised Statutes — official online source · active · operative text
Official source